These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8132615)

  • 1. Conserved tyrosines in the alpha subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists.
    Sine SM; Quiram P; Papanikolaou F; Kreienkamp HJ; Taylor P
    J Biol Chem; 1994 Mar; 269(12):8808-16. PubMed ID: 8132615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive antagonists bridge the alpha-gamma subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions.
    Fu DX; Sine SM
    J Biol Chem; 1994 Oct; 269(42):26152-7. PubMed ID: 7929328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor.
    Osaka H; Sugiyama N; Taylor P
    J Biol Chem; 1998 May; 273(21):12758-65. PubMed ID: 9582301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of d-tubocurarine analogs with the mouse nicotinic acetylcholine receptor. Ligand orientation at the binding site.
    Papineni RV; Pedersen SE
    J Biol Chem; 1997 Oct; 272(40):24891-8. PubMed ID: 9312090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists.
    Kearney PC; Nowak MW; Zhong W; Silverman SK; Lester HA; Dougherty DA
    Mol Pharmacol; 1996 Nov; 50(5):1401-12. PubMed ID: 8913372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation kinetics of recombinant mouse nicotinic acetylcholine receptors: mutations of alpha-subunit tyrosine 190 affect both binding and gating.
    Chen J; Zhang Y; Akk G; Sine S; Auerbach A
    Biophys J; 1995 Sep; 69(3):849-59. PubMed ID: 8519985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orientation of d-tubocurarine in the muscle nicotinic acetylcholine receptor-binding site.
    Willcockson IU; Hong A; Whisenant RP; Edwards JB; Wang H; Sarkar HK; Pedersen SE
    J Biol Chem; 2002 Nov; 277(44):42249-58. PubMed ID: 12196523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site.
    Pedersen SE; Papineni RV
    J Biol Chem; 1995 Dec; 270(52):31141-50. PubMed ID: 8537377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-receptor interactions in the nicotinic acetylcholine receptor probed using multiple substitutions at conserved tyrosines on the alpha subunit.
    Aylwin ML; White MM
    FEBS Lett; 1994 Jul; 349(1):99-103. PubMed ID: 8045310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists.
    Bren N; Sine SM
    J Biol Chem; 1997 Dec; 272(49):30793-8. PubMed ID: 9388220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anionic residue in the alpha-subunit of the nicotinic acetylcholine receptor contributing to subunit assembly and ligand binding.
    Sugiyama N; Boyd AE; Taylor P
    J Biol Chem; 1996 Oct; 271(43):26575-81. PubMed ID: 8900129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective enhancement of the interaction of curare with the nicotinic acetylcholine receptor.
    Filatov GN; Aylwin ML; White MM
    Mol Pharmacol; 1993 Aug; 44(2):237-41. PubMed ID: 8355663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.
    Wang HL; Gao F; Bren N; Sine SM
    J Biol Chem; 2003 Aug; 278(34):32284-91. PubMed ID: 12799358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curariform antagonists bind in different orientations to acetylcholine-binding protein.
    Gao F; Bern N; Little A; Wang HL; Hansen SB; Talley TT; Taylor P; Sine SM
    J Biol Chem; 2003 Jun; 278(25):23020-6. PubMed ID: 12682067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of ligand-induced activation of the Torpedo acetylcholine receptor.
    O'Leary ME; White MM
    J Biol Chem; 1992 Apr; 267(12):8360-5. PubMed ID: 1569088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural differences in the two agonist binding sites of the Torpedo nicotinic acetylcholine receptor revealed by time-resolved fluorescence spectroscopy.
    Martinez KL; Corringer PJ; Edelstein SJ; Changeux JP; Mérola F
    Biochemistry; 2000 Jun; 39(23):6979-90. PubMed ID: 10841780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.